Home / Therapeutic Area / Peptide Therapeutics Pipeline Database: 1-Year Subscription

Peptide Therapeutics Pipeline Database: 1-Year Subscription

By: La Merie Publishing
Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files.
 
Each project (file) is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of therapeutic peptides is intuitive. Data sets of interest can be printed and exported in Word or Excel format. Projects are being updated continuously by passive and active searches. Information from press releases is entered on a daily basis. Active searches for targets, indications, company pipelines, scientific congresses, corporate releases, publications and in other sources are conducted on a rotating, regular basis.
 
The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. A scroll down menu for predefined targets and therapeutic areas (e.g. Anti-Inflammatory Peptides) conveniently selects projects of interest:
 
  • Anti-Infective Peptides
  • Anti-Inflammatory Peptides
  • Cardiovascular Peptides
  • Cardiometabolic Peptides
  • Cancer Peptides
  • GLP-1 Receptor Agonists (only peptides)
  • PTH Receptor Agonists (only peptides)
  • Peptides Sales in 2013
An advanced search function allows to combine search parameters. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, therapeutic area or company name. Sample screenshots illustrate the database.

NA

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +